DIPEPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug DIPEPRO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII GV54A213NN - TRYPSIN, UNSPECIFIED FORM
 
Read more about Trypsin
2
Chymotrypsin
UNII BVS505O332 - CHYMOTRYPSIN

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
C4-1323 Tablet Dipepro Tablets TAB 50,000 units (6:1) Each tablet contains: Trypsin-Chymotrypsin (6:1 Approx.) equiv. to 50,000 units of proteolytic enzyme activity 30/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M09AB52 Trypsin, combinations M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AB Enzymes
Discover more medicines within M09AB52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database C4-1323

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈